Literature DB >> 15818446

Successful treatment of chronic venous leg ulcers with lyophilized cultured epidermal allografts.

V Slonková1, Z Navrátilová, V Semrádová, J Adler.   

Abstract

The case of a 67-year-old woman with chronic venous leg ulcers and severe gonarthrosis is described. In spite of intensive therapy, the leg ulcers had persisted for 4 years and made the intended orthopaedic operation of the right knee impossible. The patient was treated with lyophilized cultured epidermal allografts and her leg ulcers healed within 40 days. Lyophilized cultured epidermal allografts represent a modern type of active wound dressing that leads to rapid healing of chronic venous leg ulcers and enables patients to undergo surgical intervention.

Entities:  

Year:  2004        PMID: 15818446

Source DB:  PubMed          Journal:  Acta Dermatovenerol Alp Pannonica Adriat        ISSN: 1318-4458


  4 in total

1.  Effectiveness and tissue compatibility of a 12-week treatment of chronic venous leg ulcers with an octenidine based antiseptic--a randomized, double-blind controlled study.

Authors:  Wolfgang Vanscheidt; Keith Harding; Luc Téot; Jörg Siebert
Journal:  Int Wound J       Date:  2011-11-10       Impact factor: 3.315

2.  Wound-healing potential of Cultured Epidermal Sheets is unaltered after lyophilization: a preclinical study in comparison to cryopreserved CES.

Authors:  H Jang; Y H Kim; M K Kim; K H Lee; S Jeon
Journal:  Biomed Res Int       Date:  2013-12-18       Impact factor: 3.411

Review 3.  Autologous Cell Seeding in Tracheal Tissue Engineering.

Authors:  Elizabeth F Maughan; Robert E Hynds; Toby J Proctor; Sam M Janes; Martin Elliott; Martin A Birchall; Mark W Lowdell; Paolo De Coppi
Journal:  Curr Stem Cell Rep       Date:  2017-10-26

4.  Dried human cultured epidermis accelerates wound healing in diabetic mouse skin defect wounds.

Authors:  Michiharu Sakamoto; Takashi Nakano; Itaru Tsuge; Hiroki Yamanaka; Yasuhiro Katayama; Yoshihiro Shimizu; Yoshika Note; Masukazu Inoie; Naoki Morimoto
Journal:  Sci Rep       Date:  2022-02-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.